CYP 3.85% 25.0¢ cynata therapeutics limited

This study was likely guided by the FDAs decision regarding MSBs...

  1. 174 Posts.
    lightbulb Created with Sketch. 85
    This study was likely guided by the FDAs decision regarding MSBs GVHD. Need to demonstrate the exact cellular mechanisms by which the MSCs cause effect. Then match this to in vitro testing of CYP product to demonstrate every dose will be equivocal in effect.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.010(3.85%)
Mkt cap ! $44.90M
Open High Low Value Volume
26.0¢ 26.5¢ 25.0¢ $5.869K 22.42K

Buyers (Bids)

No. Vol. Price($)
1 29342 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 30000 1
View Market Depth
Last trade - 15.47pm 11/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.